Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
S

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Identifying Target Cancer-Antigen, Mesothelin Directed CAR T Therapy & Saving T-Cells from Exhaustion

By 5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure FEATURING Shanu Modi
By 5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure FEATURING Shanu Modi
826 views
September 24, 2019
Comments 2
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Breast
06:39

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

578 views
06:55

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpe…

Insights from 2023 ESMO Annual Meeting

K. Jhaveri

152 views
21:26

Early Diagnosis and Updates in Breast Cancer

Memorial Sloan Kettering Cancer Center

V. Sacchini

166 views
27:27

ASCO 2022 HR+ Breast Cancer Updates

Nebraska Oncology Society

C. Dang

595 views
05:51

ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates

Nebraska Oncology Society

C. Dang

49 views
09:47

ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates

Nebraska Oncology Society

C. Dang

72 views
09:57

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

ASCO 2022 Conference Coverage

C. Dang

198 views
01:06

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

ASCO 2022 Conference Coverage

C. Dang

40 views
05:41

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MB…

ecancer

S. Modi

37 views
05:57

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of …

ecancer

S. Modi

218 views
06:32

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

ASCO 2022 Conference Coverage

S. Shen

364 views
01:37

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

ASCO 2022 Conference Coverage

S. Shen

18 views
20:08

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Memorial Sloan Kettering Cancer Center

N. Iyengar

662 views
28:05

2022 Inherited Breast Cancer Risk Assessment and Reduction: What's N…

University of Kansas Cancer Center Post San Antonio Review

M. Robson

44 views
53:46

HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors

PleXus Communications

K. Jhaveri

338 views
07:16

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

SABCS 2021 Conference Coverage on VuMedi

A. Barrio

13 views
13:08

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

SABCS 2021 Conference Coverage on VuMedi

K. Jhaveri

277 views
24:21

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

SABCS 2021 Conference Coverage on VuMedi

A. Xu

505 views
20:23

Will Surgery Be a Part of Breast Cancer Treatment in the Future?

Memorial Sloan Kettering Cancer Center

M. Morrow

3.8K views
26:50

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

S. Modi

826 views